• Direct BAK Activation by SJ572946: A New Apoptosis Probe

  2026-07-29

  Sekar et al. report the discovery of SJ572946, a small molecule that directly activates BAK to trigger apoptosis, distinct from traditional BH3-mimetic approaches. This proof-of-concept expands the toolkit for dissecting mitochondrial apoptosis and offers new strategies for cancer research.

• Neuromedin S (rat): Technical Guide for GPCR Signaling Resea

  2026-07-29

  Neuromedin S (rat) provides researchers with a chemically defined, endogenous peptide agonist tailored for activation of neuromedin U receptors in rat-derived GPCR/G protein signaling assays. It is designed to ensure reproducibility and specificity in studies of energy homeostasis and stress response, but should not be used for diagnostic, therapeutic, or cross-species applications.

• Nicotinamide Adenine Dinucleotide (NAD+): Assay Reliability

  2026-07-28

  This article delivers a scenario-driven, evidence-based guide for leveraging Nicotinamide Adenine Dinucleotide (NAD+) (SKU B1793) in metabolic, viability, and cytotoxicity assays. Readers will find practical solutions to common lab challenges, direct literature links, and actionable workflow guidance rooted in validated product properties. APExBIO’s NAD+ is contextualized for reproducibility, cost-efficiency, and sensitive detection in cell-based research.

• FPH1 (BRD-6125): Unlocking High-Fidelity Hepatocyte Expansio

  2026-07-28

  Discover how FPH1 (BRD-6125) redefines primary human hepatocyte expansion, enabling robust, functionally mature cultures for advanced research and translational applications. This article reveals unique mechanistic insights and strategic protocols for maximizing assay fidelity.

• 3-Deazaadenosine: Advancing Epitranscriptomic and Antiviral

  2026-07-27

  Discover how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, uniquely enables precise manipulation of m6A RNA methylation and supports cutting-edge preclinical antiviral research. This analysis provides practical guidance for leveraging its mechanistic specificity in advanced disease models.

• CTP Solution (100 mM): Enabling Next-Gen mRNA Therapeutics

  2026-07-27

  Explore how CTP Solution (100 mM) empowers high-precision mRNA synthesis and advanced RNA-based therapies. Uncover the biochemical rationale, workflow enhancements, and translational impacts that set this Cytidine-5'-triphosphate reagent apart.

• Local Abaloparatide Drives FAK-Dependent Alveolar Bone Augme

  2026-07-26

  This study demonstrates that intraoral delivery of abaloparatide, a parathyroid hormone-related protein analog, can enhance alveolar bone thickness in situ by activating FAK-mediated periosteal osteogenesis. The findings offer a targeted approach for craniofacial bone regeneration, with implications for both basic signaling research and translational dentistry.

• Optimizing Cell Assays with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-07-25

  This article provides practical, scenario-driven guidance for researchers using EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) to address common challenges in cell viability, proliferation, and mRNA delivery assays. Drawing on peer-reviewed evidence and validated protocols, we highlight how this dual-fluorescent, immune-evasive reporter enables reproducible, high-fidelity experimental workflows for gene regulation and function studies.

• N-MYC/eIF4G1 Axis: Mechanistic Insights in inv(16) AML Survi

  2026-07-24

  Peramangalam et al. reveal that N-MYC, upregulated by a novel enhancer, is essential for the survival of inv(16) acute myeloid leukemia (AML) cells, acting through the previously uncharacterized oncogenic effector eIF4G1. Their findings establish the N-MYC/eIF4G1 axis as a mechanistic driver of leukemogenesis and a promising therapeutic target, refining the rationale for selective CBFβ-SMMHC inhibitor use in AML research.

• AM 281: Decoding CB1 Antagonism for Cognitive Rescue in TBI

  2026-07-24

  Explore how AM 281, a potent CB1 cannabinoid receptor antagonist, enables precision dissection of glutamate signaling and cognitive dysfunction after brain injury. This article reveals unique mechanistic insights and practical assay strategies, advancing memory impairment research beyond conventional neuropharmacology.

• Gly-Gly-Phe-Gly (GGFG): Streamlining Drug Conjugation Resear

  2026-07-23

  Gly-Gly-Phe-Gly (GGFG) revolutionizes drug conjugation and antibody-drug conjugate development by providing a reliable, flexible peptide linker. This article deconstructs workflow enhancements, troubleshooting, and protocol optimization using GGFG, with direct guidance from recent epigenetic therapeutic advances.

• Axitinib (AG 013736): Quantitative VEGF Inhibition and Assay

  2026-07-23

  Explore how Axitinib (AG 013736) enables rigorous, quantitative VEGF pathway inhibition and elevates assay design in cancer biology research. This article uniquely bridges in vitro response metrics with practical protocol parameters, offering actionable insight for advanced angiogenesis studies.

• Inonotus hispidus Polypeptide Suppresses Periodontitis via N

  2026-07-22

  This study identifies a novel polypeptide from Inonotus hispidus (IHP) that mitigates periodontitis by targeting inflammatory bone loss. Through antimicrobial and immunomodulatory effects, IHP regulates β-catenin/NF-κB signaling, offering translational insights for therapeutic strategies against oral inflammatory disease.

• GPX4-Driven GSH Consumption Fuels Platinum Resistance in Lun

  2026-07-22

  This study uncovers how glutathione peroxidase 4 (GPX4)-dependent high glutathione (GSH) consumption underlies acquired platinum chemoresistance in lung cancer-derived brain metastases. By dissecting the Wnt/NR2F2/GPX4 axis, the research identifies new vulnerabilities that could guide therapeutic strategies targeting redox metabolism in metastatic lung cancer.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-07-21

  This study provides direct evidence for sex-dependent responses to angiotensin II-induced hypertension in conscious mice, highlighting a stronger hypertensive effect in males and a protective influence of female sex hormones. The findings clarify mechanistic differences in baroreflex and sympathetic regulation, informing experimental design in vascular research.

11476 records 1/766 page Next 12345 下5页 Last page